Ignite Creation Date:
2024-05-06 @ 8:38 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02784665
Status:
COMPLETED
Last Update Posted:
2018-08-15
First Post:
2016-05-23
Brief Title:
Treatment Trial for Acute Central Serous Chorioretinopathy
Sponsor:
Jin Chen-jin
Organization:
Sun Yat-sen University
Study Overview
Official Title:
Randomized Controlled Clinical Trial to Evaluate the Effects of 577nm Micropulse Laser vs Traditional Laser Therapy on Acute Central Serous Chorioretinopathy
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Central serous chorioretinopathy CSC is a relatively frequent eye disease in younger patients It is characterized by serous detachment of the neurosensory retina with or without serous detachment of the retinal pigment epithelium RPE which can cause vision drop image distortion loss of color and contrast vision Although nonfoveal focal leakage can be treated with traditional laser photocoagulation but it has the side effects of causing RPE atrophy scotoma or secondary CNV Photodynamic therapy PDT is another effective treatment but its more than most families can afford to pay because of the high cost whats more it is accompanied with side-effects such as choroidal ischemia retinal pigmental epithelium RPE atrophy and RPE rip
To date there is no international consensus on the optimal treatment of CSC Many retrospective studies suggest that micropulse laser MPL therapy may also be effective without obvious complications in this disease
The purpose of this study is to evaluate the effect of micropulse laser MPL on acute central serous chorioretinopathy compared with the traditional laser coagulation
To date there is no international consensus on the optimal treatment of CSC Many retrospective studies suggest that micropulse laser MPL therapy may also be effective without obvious complications in this disease
The purpose of this study is to evaluate the effect of micropulse laser MPL on acute central serous chorioretinopathy compared with the traditional laser coagulation
Detailed Description:
The study is a prospective randomized controlled trial about 577nm micropulse laser versus traditional laser coagulation therapy on acute central serous chorioretinopathy The primary outcome measures is the proportion of eyes with complete absorption of subretinal fluid 3 months after treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None